Remove Insurance Coverage and Processing Remove Pharmaceutical Companies Remove Presentation
article thumbnail

AI-driven drug discovery, precision medicine, and sustainable manufacturing can redefine the pharma industry

Express Pharma

On the global stage, AI and Machine Learning (ML) drove drug discovery and process optimisation, especially as large-scale pharma companies adopted AI for precision medicine. In India, pharmaceutical companies responded to global environmental concerns and government mandates by adopting greener manufacturing techniques.

article thumbnail

External control arms and debunking real-world data myths

pharmaphorum

Christopher Boone, global head of health economics and outcomes research at AbbVie, advises: “Evidence generation in drug development is ripe for innovation in the digital era and the expanded use of real-world evidence presents a clear enabler to saving time and money.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharmaceutical Market Access: Strategies, Challenges, and Key Trends for Success

Pharma Marketing Network

This is where pharmaceutical market access comes into play. Pharmaceutical market access refers to the process of ensuring a drug is not only approved but also commercially viable, reimbursed, and accessible to patients. Payers demand real-world evidence (RWE) and cost-effectiveness data before granting coverage.

article thumbnail

How early planning leads to successful market access and drug launch in Europe

Pharmaceutical Technology

Launching a new drug can be a risky business, with regulatory approval no guarantee that private, commercial, and government-funded insurers will reimburse it. In Europe, the pricing and reimbursement (P&R) of pharmaceuticals is governed by individual member states.

article thumbnail

Budget expectation: Bring GST rate on APIs at par with the formulations

Express Pharma

There has been an amendment under income tax provisions to disallow such expenses incurred by pharmaceutical companies in violation of MCI regulations. – For pharma and medical devices policies, the Department of Pharmaceutical is the nodal agency. –

article thumbnail

Top Performing Drug – Trikafta/Kaftrio (May Edition)

PharmaShots

The chart depicts data till 10th May 2023) Product Dashboard PharmaShots has created a product dashboard that presents key metrics and data on Trikafta/Kaftrio in a visual format. Limited Coverage: Insurance coverage and reimbursement policies may vary, leading to potential barriers for some patients in accessing Trikafta.

article thumbnail

STAT+: Pharmalittle: We’re reading about Amgen suing Colorado over drug price caps, abortion pills, and more

STAT

The evidence presented itself early this morning as the official mascots dashed about the grounds to bark about passersby, and a steady parade of driving machines could be seen from our window. ” While out-of-pocket caps on insulin indeed cut down on costs for commercially insured patients in the U.S.,